Skip to main content
SpringerLink
Log in

Postoperative Chemotherapy for Bladder Carcinoma

  • Chapter
Carcinoma of the Bladder

Part of the book series: Medical Radiology ((Med Radiol Radiat Oncol))

  • 162 Accesses

Abstract

Postoperative chemotherapy is also referred to as adjuvant chemotherapy. In this chapter we will discuss the results of cystectomy alone for invasive bladder cancer, the rationale for postoperative chemotherapy, the chemotherapeutic agents most commonly used, and the results of chemotherapy following cystectomy.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Altman CC, McCaque NJ, Ripepi AC, et al. (1972) The use of methotrexate in advanced bladder cancer. J Urol 108:271–273

    PubMed  CAS  Google Scholar 

  • Blumenreich MS, Yagoda A, natale RB, et al. (1982) Phase II trial of vinblastine sulfate for metastatic urothelial tract tumors. Cancer 50:435–437

    Article  PubMed  CAS  Google Scholar 

  • Boileau MA, Johnson DE, Chan RC, Gonzales MO (1980) Bladder carcinoma: results with preoperative radiation therapy and radical cystectomy. Urology 16:569–576

    Article  PubMed  CAS  Google Scholar 

  • Brendler CB, Steinberg GD, Marshall FF, Mostwin JL, Walch PC (1990) Local recurrence and survival following nerve-sparing radical cystoprostatectomy. J Urol 144:1137–1141

    PubMed  CAS  Google Scholar 

  • Chabner BA, Myers CE (1989) Clinical pharmacology of cancer chemotherapy. In: Devita VT Jr, Heiman S, Rosenberg SA (eds) Cancer: principles and practice of oncology. Lippincott, Philadelphia, pp 349–395

    Google Scholar 

  • Dretler SP, Ragsdale BD, Leadbetter WF (1973) The value of pelvic lymphadenectomy in the surgical treatment of bladder cancer. J Urol 109:414–418

    PubMed  CAS  Google Scholar 

  • Freiha F (1990) Treatment options for patients with invasive bladder cancer. Monogr Urol 11:34–42

    Google Scholar 

  • Freiha F, Reese J, Torti F (1996) A randomized trial of radical cystectomy versus radical cystectomy plus cisplatin, methotrexate and vinblastine chemotherapy for muscle invasive bladder cancer. J Urol 155:495–500

    Article  PubMed  CAS  Google Scholar 

  • Gagliano OR (1980) Adriamycin vs. adriamycin plus ciplatinum in transitional cell bladder carcinoma: a SWOG study. Proc Am Assoc Cancer Res 21:347

    Google Scholar 

  • Hall RR, Bloom HJG, Freeman JE, et al. (1974) Methotrexate treatment for advanced bladder cancer. Br J Urol 46:431–436

    Article  PubMed  CAS  Google Scholar 

  • Harker WG, Meyers FJ, Freiha FS, et al. (1985) Cisplatin, methotrexate and vinblastine (CMV): an effective chemotherapy regimen for metastatic transitional cell carcinoma of the urinary tract. A Northern California Oncology Group Study. J Clin Oncol 3:1463–1468

    PubMed  CAS  Google Scholar 

  • Herr H (1980) Diamminedichloride platinum II in the treat- ment of advanced bladder cancer. J Urol 123:953–955

    Google Scholar 

  • La Plante M, Brice M III (1973) The upper limits of hopeful application of radical cystectomy for vesical carcinoma: does nodal metastasis always indicate incurability? J Urol 109:261–265

    Google Scholar 

  • Lerner SP, Skinner DG, Lieskovsky G, et al. (1993) The rationale for en bloc pelvic lymph node dissection for bladder cancer patients with nodal metastasis: long term results. J Urol 149:758–761

    PubMed  CAS  Google Scholar 

  • Logothetis CJ (1988) The role of chemotherapy in the management of invasive bladder cancer. Eur Urol 14(Suppl 1):19–23

    Google Scholar 

  • Logothetis CJ, Johnson DE, Chong C, et al. (1988) Adjuvant chemotherapy of bladder cancer: a preliminary report. J Urol 139:1207–1210

    PubMed  CAS  Google Scholar 

  • Logothetis C, Swanson D, Amato R, et al. (1996) Optimal delivery of perioperative chemotherapy: primary results of a randomized prospective, comparative trial of preoperative and postoperative chemotherapy for invasive bladder cancer. J Urol 155:1241–1245

    Article  PubMed  CAS  Google Scholar 

  • Mathur VK, Krahn HP, Ramsey EW (1981) Total cystectomy for bladder cancer. J Urol 125:784–788

    PubMed  CAS  Google Scholar 

  • Merrin C (1978) Treatment of advanced bladder cancer with Cis-diamminedichloroplatinum (II NSC 119875): a pilot study. J Urol 119:493–495

    PubMed  CAS  Google Scholar 

  • Miller RS, Freiha FS, Reese JH, Ozen H, Torti FM (1993) Cisplatin, methotrexate and vinblastine plus surgical restaging for patients with advanced transitional cell carcinoma of the urothelium. J Urol 150:65–69

    PubMed  CAS  Google Scholar 

  • Montie J, Straffon RA, Steward BH (1981) Cystectomy with or without radiation therapy: a 20 year analysis. In: Proceedings of the 77th Annual Meeting of the American Urological Association, Kansas City.

    Google Scholar 

  • Natale RB, Yagoda A, Watson RC (1981) Methotrexate: an active drug in bladder cancer. Cancer: 47:1246–1249

    Article  PubMed  CAS  Google Scholar 

  • O’Bryan RM, Luce JK, Talley RW, et al. (1973) Phase II evaluation of adriamycin in human neoplasia. Cancer 32:1–5

    Article  PubMed  Google Scholar 

  • Physicians Desk Reference (1995) 49th edn. Medical Economics, Montvale, N.J.

    Google Scholar 

  • Prout GR Jr, Griffith PP, Shipley WU (1979) Bladder carcinoma as a systemic disease. Cancer 43:2532–2539

    Article  PubMed  Google Scholar 

  • Skinner DG, Lieskovsky G (1988) Management of invasive high-grade bladder cancer. In: Skinner D, Lieskovsky G (eds) Diagnosis and management of genito-urinary cancer. Saunders, Philadelphia, pp 295–312

    Google Scholar 

  • Skinner DG, Tift JP, Kaufman JJ (1982) High dose, short course preoperative radiation therapy and immediated single stage radical cystectomy with pelvic node dissection in the management of bladder cancer. J Urol 127:671–677

    PubMed  CAS  Google Scholar 

  • Skinner DG, Daniels JR, Russell CA (1991) The role of adjuvant chemotherapy following cystectomy for invasive bladder cancer: a prospective comparative trial. J Urol 145:459–464

    PubMed  CAS  Google Scholar 

  • Smith JA, Whitmore WF Jr (1981) Regional lymph node metastasis from bladder cancer. J Urol 126:591–594

    PubMed  Google Scholar 

  • Soloway MS, Murphy WM (1979) Experimental chemotherapy of bladder cancer: systemic and intravesical. Semin Oncol 6:168–172

    Google Scholar 

  • Soloway MS,Ikand M, Ford K (1981) Cis-diamminedichloroplatinum (II) in locally advanced and metastatic urothelial cancer. Cancer47:476–481

    Article  PubMed  CAS  Google Scholar 

  • Sternberg CN, yagoda A, Scher HI, et al. (1985) Preliminary results of M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for transitional cell carcinoma of the urothelium. J Urol 133:403–409

    PubMed  CAS  Google Scholar 

  • Sternberg CN, Yagoda A, Scher HI, et al. (1988) The role of chemotherapy in the management of invasive bladder cancer. Eur Urol 14(Suppl 1)24–28

    Google Scholar 

  • Stockle M, Alken P, Engelmann U, Jacobi GH, Riedmiller H, Hohenfellner R (1986) Radikale Zystecktomie-oft zu spat? Akt Urol 17:234–239

    Article  Google Scholar 

  • Stockle M, Meyenberg W, Wellek S, et al. (1992) Advanced bladder cancer (stages pT3b, pT4a, pN1 and pN2): improved survival after radical cystectomy and 3 adjuvant cycles of chemotherapy. Results of a controlled prospective study. J Urol 148:302–308

    PubMed  CAS  Google Scholar 

  • Turner AG, Hendry WF, Williams GB, et al. (1977) The treatment of advanced bladder cancer with methotrexate. Br J Urol 49: 673–678

    Article  PubMed  CAS  Google Scholar 

  • Wei CH, Hsieh RK, Chiou TJ, Chen KK, Chang LS, Chen PM (1996) Adjuvant methotrexate, vinblastine and cisplatin chemotherapy for invasive transitional cell carcinoma: Taiwan experience. J Urol 155:118–121

    Article  PubMed  CAS  Google Scholar 

  • Wishnow KI, Dmoshowski R (1988) Pelvic recurrence after radical cystectomy without preoperative radiation. J Urol 140:42–43

    PubMed  CAS  Google Scholar 

  • Wishnow KI, Levinson KA, Johnson DE, et al. (1992) Stage B (P2/3a/No) transitional cell carcinoma of the bladder is highly curable by radical cystectomy. Urology 39:12–16

    Article  PubMed  CAS  Google Scholar 

  • Yagoda A (1983) Chemotherapy for advanced urothelial cancer. Semin Urol 1:60–68

    PubMed  CAS  Google Scholar 

  • Yagoda A, Watson RC, Gonzales-Vitale JC, et al. (1976) Cisdichloro-diammine platinum (II) in advanced bladder cancer. Cancer Treat Rep 60:917–923

    PubMed  CAS  Google Scholar 

  • Yagoda A, Watson RC, Whitmore WF Jr, et al. (1977a) Adriamycin in advanced urinary tract cancer. Cancer 39:279–284

    Article  CAS  Google Scholar 

  • Yagoda A, Watson RC, Grabstald E, et al. (1977b) Adriamycin and cyclophosphamide in advanced bladder cancer. Cancer Treat Rep 61:97–101

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Urologic Oncology, Department of urology, Stanford University Medical Center, 300 Pasteur Drive, Room S-287, Stanford, CA, 94305, USA

    F. S. Freiha MD (Professor and Chief)

Authors
  1. F. S. Freiha MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Radiation Oncology, University of Southern California, USC/Norris Cancer Center, 1441 Eastlake Avenue, Los Angeles, CA, 90033, USA

    Zbigniew Petrovich MD, FACR (Professor and Chairman) (Professor and Chairman)

  2. Department of Urology, UZ Gasthuisberg, University of Leuven, Herestraat 49, B-3000, Leuven, Belgium

    Luc Baert MD, PhD (Professor and Chairman) (Professor and Chairman)

  3. Department of Radiation Oncology and Nuclear Medicine, Allegheny University Hospitals, Center City, Mail Stop 200, Broad & Vine Sts., Philadelphia, PA, 19102-1192, USA

    Luther W. Brady MD (Professor) (Professor)

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Freiha, F.S. (1998). Postoperative Chemotherapy for Bladder Carcinoma. In: Petrovich, Z., Baert, L., Brady, L.W. (eds) Carcinoma of the Bladder. Medical Radiology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-60258-0_22

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-60258-0_22

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-64323-1

  • Online ISBN: 978-3-642-60258-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation